These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 15640273)

  • 1. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
    Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity.
    Candon S; Gottenberg JE; Bengoufa D; Chatenoud L; Mariette X
    Ann Rheum Dis; 2009 Jul; 68(7):1208-12. PubMed ID: 18713786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
    Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
    Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
    Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA rheumatoid factor in primary Sjogren's syndrome.
    Peen E; Mellbye OJ; Haga HJ
    Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.
    Mariette X; Roux S; Zhang J; Bengoufa D; Lavie F; Zhou T; Kimberly R
    Ann Rheum Dis; 2003 Feb; 62(2):168-71. PubMed ID: 12525388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
    Pertovaara M; Jylhävä J; Uusitalo H; Pukander J; Helin H; Hurme M
    J Rheumatol; 2009 Nov; 36(11):2487-90. PubMed ID: 19833744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predictive of renal involvement in patients with primary Sjögren's syndrome.
    Pertovaara M; Korpela M; Pasternack A
    Clin Nephrol; 2001 Jul; 56(1):10-8. PubMed ID: 11499654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
    Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
    Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
    Willeke P; Gaubitz M; Schotte H; Becker H; Mickholz E; Domschke W; Schlüter B
    Rheumatology (Oxford); 2007 Mar; 46(3):479-83. PubMed ID: 16935916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
    Huo AP; Lin KC; Chou CT
    Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF overexpression is associated with autoantibody production in autoimmune diseases.
    Pers JO; Daridon C; Devauchelle V; Jousse S; Saraux A; Jamin C; Youinou P
    Ann N Y Acad Sci; 2005 Jun; 1050():34-9. PubMed ID: 16014518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
    Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
    Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.